Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-glutamine in Diverticulosis
NCT05106101Phase 1Completed
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of glutamine in diverticulosis. Primary endpoint: Change from baseline in the number of colonic diverticula at 12 months. Started Jul 2019; status: completed.
02
Drugs
glutamine
03
Conditions
diverticulosis
Beyond the preview
Go deeper on NCT05106101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05106101.